{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By REUTERS", "person": [], "organization": "REUTERS"}, "abstract": null, "type_of_material": "News", "word_count": "210", "lead_paragraph": "The pharmaceutical company won antitrust approval after agreeing to sell rights and assets related to 79 generic drugs to rival firms.", "pub_date": "2016-07-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva Is Approved to Purchase Allergan\u2019s Generics Business", "print_headline": "Teva Approved To Purchase  Allergan\u2019s Generics"}, "snippet": "The pharmaceutical company won antitrust approval after agreeing to sell rights and assets related to 79 generic drugs to rival firms....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/07/28/business/teva-is-approved-to-purchase-allergans-generics-business.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Allergan Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Antitrust Laws and Competition Issues", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Federal Trade Commission", "name": "organizations"}], "blog": [], "_id": "579942f738f0d87cf647e2dc", "source": "The New York Times"}